Nordea Investment Management AB Trims Stake in Unum Group (NYSE:UNM)

Nordea Investment Management AB lessened its holdings in Unum Group (NYSE:UNM) by 34.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,483,980 shares of the financial services provider’s stock after selling 780,828 shares during the period. Nordea Investment Management AB owned approximately 0.81% of Unum Group worth $108,598,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also modified their holdings of the company. Capital Performance Advisors LLP acquired a new position in Unum Group in the third quarter valued at about $31,000. Thurston Springer Miller Herd & Titak Inc. acquired a new position in shares of Unum Group in the 3rd quarter worth approximately $37,000. V Square Quantitative Management LLC boosted its position in shares of Unum Group by 38.2% during the 3rd quarter. V Square Quantitative Management LLC now owns 702 shares of the financial services provider’s stock worth $42,000 after purchasing an additional 194 shares during the period. Versant Capital Management Inc raised its position in Unum Group by 26.4% in the fourth quarter. Versant Capital Management Inc now owns 766 shares of the financial services provider’s stock valued at $56,000 after purchasing an additional 160 shares during the period. Finally, William B. Walkup & Associates Inc. acquired a new position in Unum Group during the second quarter worth $44,000. 86.57% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In other Unum Group news, EVP Timothy Gerald Arnold sold 10,000 shares of the business’s stock in a transaction on Wednesday, November 27th. The shares were sold at an average price of $76.92, for a total value of $769,200.00. Following the transaction, the executive vice president now directly owns 54,827 shares of the company’s stock, valued at approximately $4,217,292.84. The trade was a 15.43 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Elizabeth Claire Ahmed sold 5,000 shares of the stock in a transaction dated Thursday, October 31st. The stock was sold at an average price of $64.16, for a total transaction of $320,800.00. Following the transaction, the executive vice president now directly owns 58,741 shares of the company’s stock, valued at $3,768,822.56. This represents a 7.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 107,914 shares of company stock valued at $7,998,745 in the last ninety days. 0.93% of the stock is currently owned by company insiders.

Unum Group Stock Up 0.1 %

Unum Group stock opened at $73.20 on Tuesday. The stock has a market cap of $13.37 billion, a PE ratio of 7.92, a P/E/G ratio of 1.06 and a beta of 0.81. The company has a debt-to-equity ratio of 0.32, a current ratio of 0.28 and a quick ratio of 0.28. The stock’s fifty day moving average is $72.27 and its two-hundred day moving average is $61.56. Unum Group has a 1-year low of $44.83 and a 1-year high of $77.63.

Unum Group (NYSE:UNM) last issued its earnings results on Tuesday, October 29th. The financial services provider reported $2.13 earnings per share for the quarter, topping the consensus estimate of $2.10 by $0.03. The business had revenue of $3.22 billion for the quarter, compared to analyst estimates of $3.26 billion. Unum Group had a return on equity of 15.21% and a net margin of 13.76%. The business’s quarterly revenue was up 4.0% on a year-over-year basis. During the same quarter last year, the company earned $1.94 EPS. On average, sell-side analysts expect that Unum Group will post 8.54 EPS for the current fiscal year.

Unum Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 25th were given a dividend of $0.42 per share. The ex-dividend date of this dividend was Friday, October 25th. This represents a $1.68 dividend on an annualized basis and a dividend yield of 2.30%. Unum Group’s dividend payout ratio (DPR) is presently 18.18%.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on UNM shares. Evercore ISI raised Unum Group from an “in-line” rating to an “outperform” rating and lifted their price objective for the company from $67.00 to $84.00 in a research note on Thursday, November 14th. Wells Fargo & Company lifted their target price on Unum Group from $69.00 to $71.00 and gave the company an “overweight” rating in a research report on Thursday, October 10th. Truist Financial raised their price objective on shares of Unum Group from $70.00 to $75.00 and gave the company a “buy” rating in a research note on Friday, November 1st. Morgan Stanley upped their target price on shares of Unum Group from $62.00 to $64.00 and gave the stock an “equal weight” rating in a research note on Wednesday, October 30th. Finally, Barclays raised their price target on shares of Unum Group from $76.00 to $85.00 and gave the company an “overweight” rating in a research report on Monday. Four equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $73.09.

About Unum Group

Unum Group, together with its subsidiaries, provides financial protection benefit solutions primarily in the United States, the United Kingdom, Poland, and internationally. It operates through Unum US, Unum International, Colonial Life, and Closed Block segment. The company offers group long-term and short-term disability, group life, and accidental death and dismemberment products; supplemental and voluntary products, such as individual disability, voluntary benefits, and dental and vision products; and accident, sickness, disability, life, and cancer and critical illness products.